CFAs: Innovative Analytical Technologies to Improve Vaccine Manufacturing Speed and Equitable Access

The Coalition for Epidemic Preparedness Innovations (CEPI), has announced a new funding opportunity aimed at advancing innovative analytical technologies that can transform how vaccines are developed and delivered. This initiative is driven by the ambition to shorten the time required for vaccine development, manufacturing and release — ideally enabling effective vaccines to be ready within

Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members:

Subscribe Now

Scroll to Top